GlyProVac

    OverviewSuggest Edit

    GlyProVac is a company pursuing the development of glycoprotein based vaccines. It provides bacterial vaccine candidates based on its proprietary platform technology BEMAP, allowing identification of various types of O-linked protein glycosylation.
    TypePrivate
    Founded2018
    HQOdense, DK
    Websiteglyprovac.com

    Locations

    GlyProVac is headquartered in
    Odense, Denmark

    Location Map

    Latest Updates

    Employees (est.) (Nov 2021)6
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at GlyProVac

    Ann Zahle Andersen

    Ann Zahle Andersen

    CBDO and Co-Founder
    Anders Boysen

    Anders Boysen

    CEO, Co-founder and Co-inventor
    Kirsten Winther

    Kirsten Winther

    Chairman of the Board
    Show more

    GlyProVac Office Locations

    GlyProVac has an office in Odense
    Odense, DK (HQ)
    Rørhatten 4
    Show all (1)

    GlyProVac Financials and Metrics

    Summary Metrics

    Founding Date

    2018

    GlyProVac Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    97/100

    SecurityScorecard logo

    GlyProVac Online and Social Media Presence

    Embed Graph

    GlyProVac Frequently Asked Questions

    • When was GlyProVac founded?

      GlyProVac was founded in 2018.

    • Who are GlyProVac key executives?

      GlyProVac's key executives are Ann Zahle Andersen, Anders Boysen and Kirsten Winther.

    • How many employees does GlyProVac have?

      GlyProVac has 6 employees.

    • Who are GlyProVac competitors?

      Competitors of GlyProVac include Umoja Biopharma, Aprogen and Prosetta.

    • Where is GlyProVac headquarters?

      GlyProVac headquarters is located at Rørhatten 4, Odense.

    • Where are GlyProVac offices?

      GlyProVac has an office in Odense.

    • How many offices does GlyProVac have?

      GlyProVac has 1 office.